ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,916Medicare Part D Prescriptions Filled, Including Refills

Rank: 454 out of 2170

$517K Total Retail Price of All Prescriptions

Rank: 429 out of 2170

503 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 503 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 503 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 4,140 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 304 165 1 2
AMLODIPINE BESYLATE 275 154 2 4
LISINOPRIL 262 143 3 3
METFORMIN HCL 250 146 4 8
HYDROCODONE-ACETAMINOPHEN 242 120 S3 5 7
FUROSEMIDE 214 97 6 6
METOPROLOL TARTRATE 185 106 7 10
LEVOTHYROXINE SODIUM 182 80 8 5
GABAPENTIN 178 52 9 14
PRAVASTATIN SODIUM 166 95 10 11
SIMVASTATIN 156 104 11 1
TRAMADOL HCL 150 82 12 18
AZITHROMYCIN 145 80 13 47
NEXIUM 144 89 14 22
CLOPIDOGREL 141 89 15 37
OXYCODONE-ACETAMINOPHEN 107 35 S2 16 60
ISOSORBIDE MONONITRATE ER 105 54 17 50
MELOXICAM 102 43 18 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 44 19 20
CARVEDILOL 97 34 20 26
ZOLPIDEM TARTRATE 95 25 21 17
WARFARIN SODIUM 93 58 22 15
OXYCODONE HCL 90 13 S2 23 56
HYDROCHLOROTHIAZIDE 88 64 24 9
ALLOPURINOL 88 36 24 29
SERTRALINE HCL 85 39 26 25
ESCITALOPRAM OXALATE 85 42 26 75
CITALOPRAM HBR 85 61 26 19
PLAVIX 85 50 26 58
PROMETHAZINE HCL 82 20 R 30 70
ALENDRONATE SODIUM 77 56 31 36
CYCLOBENZAPRINE HCL 77 21 R 31 52
LYRICA 73 0 33 90
ATORVASTATIN CALCIUM 71 27 34 12
SPIRIVA 70 24 35 49
OXYCODONE HCL-ACETAMINOPHEN 64 23 S2 36 74
TAMSULOSIN HCL 63 48 37 33
CLONIDINE HCL 63 38 37 54
VENTOLIN HFA 61 23 39 102
RANITIDINE HCL 60 23 40 40
GLIMEPIRIDE 59 40 41 31
DIOVAN 57 32 42 53
ENDOCET 56 19 S2 43 106
PROAIR HFA 56 0 43 43
BENAZEPRIL HCL 55 50 45 55
ADVAIR DISKUS 55 30 45 45
COMBIVENT 55 24 45 112
TRAZODONE HCL 53 0 48 38
FLUTICASONE PROPIONATE 51 27 49 30
FENOFIBRATE 50 14 50 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.